Researchers confirmed a link between the use of menopause hormonal therapies and dementia and Alzheimer's, but they could not determine the cause, according to a study published June 28 in BMJ. 

Johnson City, Tenn.-based Ballad Health is using artificial intelligence to identify potential medication errors and improve pharmacy workflows, the health system said June 29. 

Convenience and cost-saving are priorities of American consumers, particularly for those who belong to Gen Z and Millennial generations, and a recent Wolters Kluwer survey found that the same goes for how they feel about prescriptions. 

In the last 30 days, Mark Cuban Cost Plus Drug Co. has spread its affiliate pharmacy network to 12 states and secured three partnerships. 

The FDA has issued a warning to wholesale drug distributor Safe Chain Solutions over four major violations — including ones related to counterfeit and unapproved drugs — which the agency found after an inspection it conducted between April and May. 

The pharmacists of tomorrow will be "stepping into the gap where physicians have previously operated," Steve Martin, PharmD, dean of Ohio Northern University's Raabe College of Pharmacy in Ada, said in a June 26 release. 

Eli Lilly's investigational obesity drug reduced phase 2 study participants' weight by 24.2 percent after nearly a year's worth of treatment, marking more significant weight loss results compared to other drugs currently being studied or on the market.

Seniors in Binghamton (N.Y.) University’s School of Pharmacy and Pharmaceutical Sciences program had the best Phase 1 match rate of any pharmacy residency applicants in the country at a rate of 96 percent, according to a June 27 news release. 

With about a dozen cancer drugs on back order and no clear end to the shortages, the American Society of Clinical Oncology and the Society of Gynecologic Oncology recently advised clinicians to ration chemotherapy supplies. 

Pullman-based Washington State University reduced out-of-state tuition for students working toward their Doctor of Pharmacy degree by 30 percent, or about $12,000, with the hopes "to remedy the acute pharmacist shortage in the state."